3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Mesothelioma, Malignant
120
Mesothelioma
70
Solid Tumor
46
Solid Tumors
33
Retinoblastoma
27
Solitary Fibrous Tumor, Pleural
20
Sarcoma
17
Advanced Solid Tumor
16
Advanced Solid Tumors
15
Lung Neoplasms
13
Small Cell Lung Carcinoma
12
Carcinoma, Non-Small-Cell Lung
11
Osteosarcoma
9
Neuroblastoma
8
Ovarian Neoplasms
7
Unspecified Adult Solid Tumor, Protocol Specific
6
Solid Tumor, Adult
6
Colorectal Neoplasms
6
Cholangiocarcinoma
6
Central Nervous System Neoplasms
6
Carcinoma, Renal Cell
6
Uterine Cervical Neoplasms
5
Thyroid Neoplasms
5
Stomach Neoplasms
5
Neoplasms
5
Melanoma
5
Medulloblastoma
5
Chondrosarcoma
5
Carcinoma, Hepatocellular
5
Breast Neoplasms
5
Interventions
amatuximab
1
Pemetrexed
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Severe combined immunodeficiency with sensitivity to ionizing radiation
×
Other solid neoplasm
×
Clear all
NCT02357147
2020-03-17
ARTEMIS
Morphotek
Phase 2
Terminated
124 enrolled
10 charts